Surmodics Inc (SRDX) Q1 2019 Earnings Conference Call Transcript - Motley Fool

Surmodics Inc (SRDX) Q1 2019 Earnings Conference Call Transcript  Motley Fool

SRDX earnings call for the period ending December 31, 2018.



Comments

Post a Comment

Popular posts from this blog

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma - Global Banking And Finance Review

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma    Global Banking And Finance Review Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...
Read more